Towards Healthcare
Oral Proteins & Peptides Market to Rise at 16.34% CAGR till 2034

Oral Proteins & Peptides Market Forecast 2025 to 2034 AI, Digital Health & Novel Delivery Devices Driving 16.34% CAGR

According to market projections, the oral proteins & peptides sector is expected to grow from USD 8.05 billion in 2024 to USD 36.35 billion by 2034, reflecting a CAGR of 16.34%. A rise in R&D investments and patient preference is boosting the global market expansion. North America led the market due to growth in the early approvals and a robust healthcare ecosystem.

  • Insight Code: 6027
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The oral proteins & peptides market stands at USD 9.36 billion in 2025 and is expected to reach USD 36.35 billion by 2034, growing at a CAGR of 16.34% from 2024 to 2034.

North America is currently leading the oral proteins & peptides market due to early approvals, reimbursement pathways, and a robust clinical development ecosystem.

The oral proteins & peptides market includes 6 segments, such as by molecule class, by therapeutic area, by delivery/technology platform, by dosage form, by end user/sponsor type, by route-to-market/channel, and by region.

The potential solutions in the oral proteins & peptides market are enzyme inhibitors, modified peptides, nanotechnology, and absorption enhancers.

To overcome challenges in the market, researchers are expanding drug delivery systems, enteric coatings, protease inhibitors, and targeted delivery.

The prospects for oral peptide therapies are a rise in R&D and wide-range clinical applications.

US FDA, NIH, NCBI, MDPI, Clinicaltrials.gov, WebMD, drugoffice.gov, ICMR